Clinical Trials Directory

Trials / Completed

CompletedNCT05528380

Development of a Lifestyle Physical Activity Intervention to Reduce Risk for Perinatal Cannabis Use

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Butler Hospital · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

This study will recruit 20 women who are high risk for prenatal cannabis use for a 12-week program of using the tracker and receiving a Lifestyle Physical Activity program. The primary outcomes will be self reported percent days of cannabis use and physical activity. Secondary outcomes include self -reported measures of depression and anxiety symptoms, adaptive coping, and self-efficacy for cannabis abstinence.

Detailed description

This study will recruit 20 women in an open trial who are high risk for prenatal cannabis use for a 12-week program of using a Fitbit activity tracker and receiving a Lifestyle Physical Activity program. The primary outcomes will be self reported percent days of cannabis use and physical activity. Secondary outcomes include self -reported measures of depression and anxiety symptoms, adaptive coping, and self-efficacy for cannabis abstinence. The investigators will clinically monitor all participants in the study for safety and clinical deterioration, and measure a variety of symptom outcomes over the course of the intervention period during pregnancy, as well as at a postpartum follow-up.

Conditions

Interventions

TypeNameDescription
BEHAVIORALLPA + Fitbit InterventionParticipants will receive a Fitbit to track activity levels and participate in a 6-session lifestyle physical activity intervention over the course of 12 weeks. The intervention consists of 20-25 minute phone or video-delivered session to: (a) review PA progress and re-evaluate current step-count goals, (b) problem-solve barriers to incorporating PA into their daily lives, (c) address difficulties utilizing the Fitbit, (d) encourage the use of bouts of PA as a coping strategy, and e) engage the participant in brief discussions focused on increasing and maintaining PA.

Timeline

Start date
2022-01-30
Primary completion
2024-05-15
Completion
2024-10-15
First posted
2022-09-06
Last updated
2026-02-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05528380. Inclusion in this directory is not an endorsement.